CytomX Therapeutics Inc (CTMX) — Free Cash Flow Generation Index
CytomX Therapeutics Inc (CTMX) has a Free Cash Flow Generation Index of 0.99x as of March 2023. Free cash flow of $9.30 Million represents 1% of operating cash flow ($9.35 Million). Explore how much does CytomX Therapeutics Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
CytomX Therapeutics Inc Free Cash Flow Generation Index (2014–2020)
Historical FCF Generation Index trend for CytomX Therapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see CytomX Therapeutics Inc (CTMX) cash conversion ratio.
Annual Free Cash Flow Generation for CytomX Therapeutics Inc (2014–2020)
Year-by-year Free Cash Flow Generation Index for CytomX Therapeutics Inc. Check cash flow reinvestment rate of CytomX Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.56x | $2.95 Million | $5.26 Million | $2.31 Million | ▼ -43.4% |
| 2017 | 0.99x | $168.81 Million | $170.37 Million | $1.56 Million | ▲ +4.6% |
| 2014 | 0.95x | $30.14 Million | $31.80 Million | $1.66 Million | — |